Evidence map›Paper›PMID 33456465›Full record

ArticleJournal of oncology2020

Demet Akdeniz Odemis, Seref Bugra Tuncer, Arash Adamnejad Ghafour, Khariga Jabbarli, Yasemin Gider, Betul Celik, Gozde Kuru Turkcan, Ozge Sukruoglu Erdogan, Seda Kilic Erciyas, Mukaddes Avsar and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Frontiers in oncology · 2021
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Demet Akdeniz OdemisIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-2271-8481
Seref Bugra TuncerIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-8023-3223
Arash Adamnejad GhafourIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-4446-7783
Khariga JabbarliIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-0728-0490
Yasemin GiderIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-4377-786X
Betul CelikIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-7923-275X
Gozde Kuru TurkcanIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-5974-4731
Ozge Sukruoglu ErdoganIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-0893-1251
Seda Kilic ErciyasIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-4417-4005
Mukaddes AvsarIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-5489-9088
Rejin KebudiIstanbul University, Oncology Institute, Division of Pediatric Hematology-Oncology, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-4344-8174
Sema Buyukkapu BayIstanbul University, Oncology Institute, Division of Pediatric Hematology-Oncology, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-2539-4662
Samuray TuncerIstanbul University, Istanbul Medical Faculty, Department of Ophthalmology, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-7491-8613
Hulya YaziciIstanbul University, Oncology Institute, Department of Basic Oncology, Division of Cancer Genetics, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-8919-0482
Istanbul University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeVarious molecular variations are known to result in different gene variants in the

methodsUsing the Sanger sequencing methods, the

resultsIn Turkish population-specific study, the

conclusionsIn patients with advanced retinoblastoma who were diagnosed with retinoblastoma prior to 24 months, the

Identifiers

PMID33456465
PMCPMC7787726
OpenAlexW3116647648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.